Dennis Peters
The Netherlands Cancer Institute(NL)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Pancreatic and Hepatic Oncology Research, Cancer Risks and Factors, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial(2019)863 cited
- → Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial(2020)391 cited
- → ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy(2015)215 cited
- → Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients(2016)158 cited
- → Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival(2018)119 cited
- → Identification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing(2013)118 cited
- → Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion(2020)117 cited
- → Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial(2023)65 cited
- → Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment(2016)60 cited
- → FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non‐small cell lung cancer(2016)46 cited